Latest Breaking News On - Samantha semenkow - Page 1 : comparemela.com

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Greece
United-states
Japan
America
Japanese
Greek
Steven-miller
Dydo-pharma
Michael-kalb
Mike-kalb
Jason-gerberry
Joon-lee

1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?

1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Samantha-semenkow
Citigroup
Editas-medicine

Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript

Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United-states
California
America
American
Brian-cheng
Mary-kate
Erick-lucera
Samantha-semenkow
Cristi-barnett
Linda-burkly
Bristol-myers-squibb
Greg-whitehead